DKSH has upgraded its cold chain infrastructure in Southeast Asia as both small and large manufacturers increase their access needs to emerging markets.
Globalisation, outsourcing and a move towards biopharmaceuticals are leading innovation for pharma distribution companies, according to DHL Global Forwarding.
Biostar Pharmaceuticals has blamed end-of-year losses on last year’s chromium-tainted gelatin scandal though it is slowly recovering following a suspension of sales enforced by the SFDA.
French biotech company ANGANY Genetics says its new platform can provide pharma companies low cost and high quality recombinant allergens for drug testing purposes.
The US FDA is giving generic drug facilities one month to self-identify for FY 2014 so that the agency can calculate how much to charge the companies in user fees for application reviews and inspections.
Thermo Fisher Scientific has agreed to purchase genetic testing equipment maker Life Technologies for $13.6B in one of the biggest acquisitions of the year.
The US FDA has opened for public comment a new ICH draft guideline that aims to help manufacturers identify and control mutagenic impurities during the development of new drugs.
Following recent acquisitions in the contract packaging industry, Frazier Healthcare says it can compete against insourcing and will lead innovation by focusing on serialization and new technologies.
The US drought of the TB treatment isoniazid may soon ease after some manufacturers on the US FDA drug shortage list resume supply, but rationing looks set to continue for now.
President Obama’s FY 2014 budget request of $4.7B for the US FDA would increase the agency’s ability to inspect foreign drug manufacturers and clinical trial sites.
An uptick in the outsourcing of preclinical trials is expected as pharmaceutical companies look to restructure and cut costs, but that increase won't necessarily begin in 2013, according to an analyst.
Novartis, the J. Craig Venter Institute, Synthetic Genomics Vaccines and the US CDC are racing to develop a vaccine for the H7N9 influenza virus sweeping through China.
India’s Directorate General of Foreign Trade (DGFT) has pushed back the deadline again for adopting new barcodes to track pharmaceutical exports by one year.
Recent changes to EU drug risk-benefit reporting rules mean more work for multinational Pharmas but are still an improvement on ‘old-style’ PSURs says EFPIA.
Ongoing shortages of the API isoniazid are forcing US state health departments to ration TB (tuberculosis) drugs and - for some patients - forego treatment altogether, a Johns Hopkins University expert told us.
China and India have more work to do to confirm their API manufacturing sites comply with EU GMP requirements, according to the European Commission’s Pharmaceutical Committee.
J. Knipper and Co. claims the acquisition of InVentiv Health’s sample management and fulfillment business makes it the largest manufacturer-to-physician drug sample services firm in the US.
Concern over controversial new Indian rules on trial participant compensation for study-related injuries is likely to spark changes that may be difficult and time consuming to implement, according to industry sources.
B-MS' (Bristol-Myers Squibb's) selection of LabCorp as its preferred provider for central lab services could be bad news for rival Icon according to industry observers.
Following its re-elevation to a ministerial level, the Chinese drug regulatory body has rebranded itself the China Food and Drug Administration (CFDA).
ACRO (Association of Contract Research Organizations) is calling on the FDA to clarify draft guidance attempting to mitigate the possible pitfalls in transitioning to electronic source data for clinical investigations.
Sale of medicines on trains and planes is just one reform being considered in a series of simplification measures aimed at increasing industry efficiency by the MHRA.
CRO (clinical research organization) employees are switching jobs at dramatically higher rates than their counterparts in other industries, especially overseas, according to a survey on CRO compensation.
Pfizer’s Rifampin injections used to treat TB (tuberculosis) are in short supply as the company says manufacturing issues caused some vials and solutions of the drug to be possibly contaminated.
DKSH says its contract extension with Bayer in Cambodia strengthens its position as a service provider for pharmaceutical companies throughout Southeast Asia.
Drug industry groups welcomed corporate tax cuts and increased research credits set out in the UK budget last night suggesting they are good news for manufacturers.
Health Canada says moving to an electronic filing system for regulatory submissions will reduce costs but warned drugmakers not to include their credit card details.
The US FDA listed failure to ensure product sterility or explain why some batches were only partially released among criticisms of Apotex in a warning letter published this week.
Vindon says its investments in its Irish and Californian facilities come as pharma companies shift to outsourcing stability storage in order to save costs.
The long-term distribution deal with Walgreens and Alliance Boots is expected to add an incremental $28 billion in revenues, according to AmerisourceBergen.
Marketed drugs will not need to be tested under final guidelines on 'tablet scoring' for branded and generic medicines issued by the US Food and Drug Administration (FDA) this week.
